ThursdayMay 27, 2021 11:55 am

QualityStocksNewsBreaks – Healthy Extracts Inc.’s (HYEX) Leading Products Backed by Research, Clinical Studies

Healthy Extracts (OTCQB: HYEX), through its two subsidiaries, BergaMet NA(TM) and Ultimate Brain Nutrients(TM) (“UBN”), is focused on the research, development and sale of natural plant-based formulations offering benefits for cardiovascular and neuro health. The targeting of these two high-growth categories reflects Healthy Extracts’ commitment to strengthening its position in the multibillion nutraceuticals market. “Research and clinical studies show positive results for two leading products of the company, BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster. Clinical studies show positive results in brain activation, sports vision, cognitive function, clarity, energy, and ketone benefits (https://ibn.fm/WGKZN),” reads a recent…

Continue Reading

ThursdayMay 27, 2021 11:39 am

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Strengthens Balance Sheet with Veteran Hemp

Hero Technologies (OTC: HENC) recently received an independent third-party valuation and purchase price allocation for the acquisition of the assets of Veteran Hemp Co. “In November 2020, Hero Technologies entered into a purchase agreement to acquire all the assets of Veteran Hemp Co. from Patriot Shield National LLC,” reads a recent article. Veteran Hemp Co., which offers hemp that is tested, tasted and veteran approved, is committed to providing quality, consistent, delicious product, and it accomplishes this by working with the best farmers in the country, delivering the best genetics, helping at every point along the way, and packaging only…

Continue Reading

ThursdayMay 27, 2021 10:55 am

QualityStocksNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Secures Purchase Order from British Columbia LDB

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, today announced that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., through its distribution partner, has received an initial purchase order for its edible cannabis gummies from the British Columbia Liquor Distribution Branch (“LDB”). Demand for Pure Extracts’ Pure Chews branded THC and CBD gummies is strong within the provincial markets, where the company anticipates that Fire Burst, like its U.S. counterpart, will be one of the top selling gummies. “The edible gummie business is a material…

Continue Reading

ThursdayMay 27, 2021 10:54 am

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) CEO Makes Guest Appearance on Bit5ive Podcast

ISW Holdings (OTC: ISWH) president and CEO Alonzo Pierce was a featured guest speaker on a recent episode of the Waypoint podcast; he was joined by Robert Collazo of Bit5ive LLC. During the podcast, the two men talked about the partnership between the two companies, as well as the nuances of mining crypto and where ISWH hopes to be in the future. ISW Holdings is a global brand management holdings company with commercial operations in telehealth and renewable energy cryptocurrency mining. Collazo shared how he got started in the space at the beginning of the crypto revolution while Pierce noted…

Continue Reading

ThursdayMay 27, 2021 10:42 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Partners with Olympic Gold Medalist and World Champion Kaillie Humphries

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness company offering premium probiotic supplements and products containing CBD, today announced an exclusive partnership with two-time Olympic Gold Medalist and five-time World Champion Kaillie Humphries. According to the update, HempFusion CBD and Probulin Probiotics will be Kaillie’s exclusive sponsors in their respective categories through February’s Olympic Games in Beijing 2022 where she is the front-runner for gold for Team USA in both the Two-woman Bobsleigh and the newly introduced Women’s Monobob. “I’m excited to join the HempFusion family of brands,” said Humphries. “When you train as hard…

Continue Reading

ThursdayMay 27, 2021 10:02 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces Completion of New Deli Acquisition

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has completed the acquisition of all of the issued and outstanding membership interests of MK Cuisine Global LLC’s (“MKC”) Plant-Based Deli LLC, or New Deli. The transaction had been previously announced and was completed through PLTXF’s wholly owned subsidiary PlantX Lifestyle USA Inc. In total, the acquisition came in at a purchase price of $1,569,999, which was reached through an exchange of a combination of $470,999.70 in cash and 2,515,983 common shares in the authorized capital of the company. A sustainable and plant-based neighborhood bodega, New Deli is situated in Venice Beach, California, where it provides practical, everyday retail…

Continue Reading

ThursdayMay 27, 2021 9:46 am

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) to Retire 107M Restricted Common Shares

Asia Broadband (OTC: AABB) today announced that its management and board of directors have approved the retirement and return of 107 million restricted common shares to the company treasury. According to the update, the share retirement process has been initiated with AABB’s transfer agent and is anticipated to be completed in the coming weeks. Asia Broadband’s initiative to create shareholder value led to the agreements with several third-party shareholders to retire the shares. With ongoing plans to continue the shareholder value initiative, AABB expects to retire additional shares to the company treasury in the near future. To view the full…

Continue Reading

WednesdayMay 26, 2021 1:51 pm

QualityStocksNewsBreaks – Why BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Is ‘One to Watch’

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), based in British Columbia, Canada, and founded in 2017, is a diversified health and wellness beverage and natural products company. BevCanna is focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements. The company offers end-to-end turnkey beverage manufacturing solutions. A recent article discussing this reads, “BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white-label beverage manufacturing solution.” To view the full article,…

Continue Reading

WednesdayMay 26, 2021 1:35 pm

QualityStocksNewsBreaks – Infobird Software Co. Ltd.’s (NASDAQ: IFBD) Smart Solutions Enable Companies to Focus on Key Operations

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, is building next-level operations in the field of AI-driven customer engagement. Infobird has built a solid reputation as a premier provider of customer engagement software-as-a-service (“SaaS”) solutions in China, leveraging automated and smart capabilities to maximize value for its clients. “The company’s self-developed cloud-native architecture and patented AI technologies, for example, work with a no-code development platform,” reads a recent article. This structure “allows enterprise-building companies to focus on managing their operations as they know best, while relying on the technological expertise of application builders for only the most…

Continue Reading

WednesdayMay 26, 2021 1:24 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Study Promising Candidate in Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is on track to begin a potentially pivotal Phase 2 trial during the second quarter of 2021. This trial of CNSP’s lead drug candidate, Berubicin, in the treatment of glioblastoma multiforme (“GBM”) is currently planned to include up to 243 subjects, randomized 2:1 (162 Berubicin/81 Lomustine) with an interim analysis when 50% of the subjects reach six months in the study. “As the first anthracycline to cross the blood-brain barrier, Berubicin was specifically designed to attack a variety of primary brain cancers and cancers metastatic to the brain,” reads a recent article on the novel candidate.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered